ATE1146T1 - 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung. - Google Patents

3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung.

Info

Publication number
ATE1146T1
ATE1146T1 AT79103245T AT79103245T ATE1146T1 AT E1146 T1 ATE1146 T1 AT E1146T1 AT 79103245 T AT79103245 T AT 79103245T AT 79103245 T AT79103245 T AT 79103245T AT E1146 T1 ATE1146 T1 AT E1146T1
Authority
AT
Austria
Prior art keywords
compositions
hydroxy
benzoacid
chlorine
derivatives
Prior art date
Application number
AT79103245T
Other languages
English (en)
Inventor
Chao-Min Liu
John Westley
Original Assignee
F. Hoffmann-La Roche & Co. Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. Aktiengesellschaft filed Critical F. Hoffmann-La Roche & Co. Aktiengesellschaft
Application granted granted Critical
Publication of ATE1146T1 publication Critical patent/ATE1146T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
AT79103245T 1978-09-22 1979-09-03 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung. ATE1146T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/944,825 US4221724A (en) 1978-09-22 1978-09-22 Antibiotic X-14766A
EP79103245A EP0009636B1 (de) 1978-09-22 1979-09-03 3-Chlor-6-Hydroxy-5-Methyl-Benzoesäure-Derivate, die entsprechenden pharmazeutischen Zusammensetzungen, das Wachstum bestimmter Tiere stimulierende Zusammensetzungen und deren Herstellung

Publications (1)

Publication Number Publication Date
ATE1146T1 true ATE1146T1 (de) 1982-06-15

Family

ID=25482136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103245T ATE1146T1 (de) 1978-09-22 1979-09-03 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung.

Country Status (5)

Country Link
US (1) US4221724A (de)
EP (1) EP0009636B1 (de)
JP (1) JPS5545681A (de)
AT (1) ATE1146T1 (de)
DE (1) DE2963010D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302470A (en) * 1980-07-21 1981-11-24 Research Corporation Acanthifolic acid--new anti-tumor and antibiotic agent
US4314057A (en) * 1980-07-21 1982-02-02 Research Corporation Acanthifolic acid-new antitumor and antibiotic agent
US4394377A (en) * 1981-07-31 1983-07-19 Syntex (U.S.A.) Inc. Ruminant animal performance by co-administering choline and propionate enchancers
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US5041374A (en) * 1986-05-29 1991-08-20 International Minerals & Chemical Corp. Polyether antibiotic recovery and purification
US5047338A (en) * 1986-05-29 1991-09-10 International Minerals & Chemical Corp. Polyester Antibiotic preparation
US5049495A (en) * 1986-05-29 1991-09-17 International Minerals & Chemical Corp. Fermentation method for producing polyether antibiotics
DE60136067D1 (de) * 2000-04-26 2008-11-20 Meiji Seika Kaisha Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2353031C2 (de) * 1972-10-27 1985-02-21 Brevetti Gabbiani S.p.A., Podenzano, Piacenza Vorrichtung zur Weiterleitung von Gegenständen in einem Winkel, insbesondere für Verarbeitungsstrecken von Plattenelementen
US4083968A (en) * 1974-07-19 1978-04-11 Hoffmann-La Roche Therapeutic agent for improving cardiovascular function

Also Published As

Publication number Publication date
US4221724A (en) 1980-09-09
JPS5545681A (en) 1980-03-31
EP0009636B1 (de) 1982-06-02
DE2963010D1 (en) 1982-07-22
EP0009636A2 (de) 1980-04-16
EP0009636A3 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
ES485062A1 (es) Un procedimiento para preparar derivados de acido acetico
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE3587777T2 (de) Heterozyklische Verbindungen, deren Herstellung und Medikamente diese enthaltend.
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
AU3531989A (en) Treatment of skin diseases and tumors
SE8400332L (sv) Forening for anvendning som mellanprodukt vid framstellning av lekemedel
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE1146T1 (de) 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung.
ES439803A1 (es) Un procedimiento para la preparacion de aminas.
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
AU532982B2 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2- carboxylic acid esters
DE3684186D1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
SE7707274L (sv) Derivat av kinoxalin-1-4-dioxider och forfarande for framstellning derav
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
FR2373539A1 (fr) Derives de l'acide dithiocarbamique, leur procede de preparation et leur application en medecine veterinaire
FR2315932A1 (fr) Derives d'acides quinoleine-carboxyliques et medicaments qui en contiennent
ATE28189T1 (de) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3carbonitrile, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die prophylaxe und therapie thrombotischer zustaende.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee